Lacutamab in patients with advanced mycosis fungoides according to KIR3DL2 expression: stage 1 results from the TELLOMAK phase 2 trial
Title:
Lacutamab in patients with advanced mycosis fungoides according to KIR3DL2 expression: stage 1 results from the TELLOMAK phase 2 trial
Author:
Bagot, M Muller, M Kim, YH Ortiz-Romero, PL Zinzani, PL Beylot-Barry, M Dalle, S Jacobsen, E Combalia, A Huen, A Mehta-Shah, N Khodadoust, MS Viotti, J Paiva, C Porcu, P